Role of methylated septin 9 as an adjunct diagnostic and prognostic biomarker in hepatocellular carcinoma. Issue 10 (October 2021)
- Record Type:
- Journal Article
- Title:
- Role of methylated septin 9 as an adjunct diagnostic and prognostic biomarker in hepatocellular carcinoma. Issue 10 (October 2021)
- Main Title:
- Role of methylated septin 9 as an adjunct diagnostic and prognostic biomarker in hepatocellular carcinoma
- Authors:
- Bannaga, Ayman S.
Alvarez, Rocio
Zhou, Lisa
Petchey, Michael
Noufaily, Angela
Hitchins, Megan P.
Arasaradnam, Ramesh P. - Abstract:
- Abstract: Background: Methylated septin 9 (mSEPT9) has a role in hepatocarcinogenesis. We evaluated mSEPT9 performance in patients with hepatocellular carcinoma (HCC) and those at risk of HCC Methods: Using Epi-proColon® V2.0 assay adapted for 1 mL plasma, we investigated mSEPT9 sensitivity, specificity, associations with influential covariates and relation to death. Results: Of 141 participants included, 136 had liver disease, 38 with HCC (mean-age 71 years) and 103 without HCC (mean-age 56.8 years), with further five without liver disease. 41 patients died (23 HCC) by the end of the study follow-up period. In HCC, mSEPT9 sensitivity and specificity were 89.47% (CI:75.20%–97.06%) and 81.55% (CI:72.70%–88.51%), whilst alpha fetoprotein (AFP) sensitivity and specificity were 50% (CI:33.38%–66.62%) and 97.09% (CI:91.72%–99.40%), respectively. Age-adjusted logistic regression showed mSEPT9 was associated with age, body mass index, HCC, liver cirrhosis, AFP, platelets, neutrophil-to-lymphocyte-ratio, albumin-bilirubin grade and fibrosis-4 index (p < 0.05). Odds for HCC patients to have positive mSEPT9 were 27.4 times more than those without HCC. Time-to-death was associated with mSEPT9 positivity (p < 0.05). Kaplan–Meier curves showed higher HCC survival with mSEPT9 compared to AFP. Conclusions: The mSEPT9 offers potential diagnostic and prognostic biomarker for HCC. After adjusting for age, mSEPT9 remained associated with liver function, liver fibrosis and inflammatoryAbstract: Background: Methylated septin 9 (mSEPT9) has a role in hepatocarcinogenesis. We evaluated mSEPT9 performance in patients with hepatocellular carcinoma (HCC) and those at risk of HCC Methods: Using Epi-proColon® V2.0 assay adapted for 1 mL plasma, we investigated mSEPT9 sensitivity, specificity, associations with influential covariates and relation to death. Results: Of 141 participants included, 136 had liver disease, 38 with HCC (mean-age 71 years) and 103 without HCC (mean-age 56.8 years), with further five without liver disease. 41 patients died (23 HCC) by the end of the study follow-up period. In HCC, mSEPT9 sensitivity and specificity were 89.47% (CI:75.20%–97.06%) and 81.55% (CI:72.70%–88.51%), whilst alpha fetoprotein (AFP) sensitivity and specificity were 50% (CI:33.38%–66.62%) and 97.09% (CI:91.72%–99.40%), respectively. Age-adjusted logistic regression showed mSEPT9 was associated with age, body mass index, HCC, liver cirrhosis, AFP, platelets, neutrophil-to-lymphocyte-ratio, albumin-bilirubin grade and fibrosis-4 index (p < 0.05). Odds for HCC patients to have positive mSEPT9 were 27.4 times more than those without HCC. Time-to-death was associated with mSEPT9 positivity (p < 0.05). Kaplan–Meier curves showed higher HCC survival with mSEPT9 compared to AFP. Conclusions: The mSEPT9 offers potential diagnostic and prognostic biomarker for HCC. After adjusting for age, mSEPT9 remained associated with liver function, liver fibrosis and inflammatory surrogate markers. Graphical abstract: Image 1 … (more)
- Is Part Of:
- HPB. Volume 23:Issue 10(2021)
- Journal:
- HPB
- Issue:
- Volume 23:Issue 10(2021)
- Issue Display:
- Volume 23, Issue 10 (2021)
- Year:
- 2021
- Volume:
- 23
- Issue:
- 10
- Issue Sort Value:
- 2021-0023-0010-0000
- Page Start:
- 1595
- Page End:
- 1606
- Publication Date:
- 2021-10
- Subjects:
- Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005 - Journal URLs:
- https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.hpb.2021.03.015 ↗
- Languages:
- English
- ISSNs:
- 1365-182X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 19632.xml